Zenith Capital Corp
Zenith Capital Corp., a biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs. The company's lead compound ZEN-3694, which is in Phase 2 clinical trial for the treatment of metastatic castration resistant prostate cancer in collaboration with Astellas and Newsoara, as well as advanced or meta… Read more
Market Cap & Net Worth: Zenith Capital Corp (ZHCLF)
Zenith Capital Corp (PINK:ZHCLF) has a market capitalization of $7.97 Million ($7.97 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #29824 globally and #9862 in its home market, demonstrating a 49900.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zenith Capital Corp's stock price $0.05 by its total outstanding shares 159315161 (159.32 Million).
Zenith Capital Corp Market Cap History: 2020 to 2025
Zenith Capital Corp's market capitalization history from 2020 to 2025. Data shows growth from $71.69 Million to $7.97 Million (130.26% CAGR).
Zenith Capital Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zenith Capital Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
15.93x
Zenith Capital Corp's market cap is 15.93 times its annual revenue
1740.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $7.97 Million | $500.00K | -$7.35 Million | 15.93x | N/A |
Competitor Companies of ZHCLF by Market Capitalization
Companies near Zenith Capital Corp in the global market cap rankings as of March 19, 2026.
Key companies related to Zenith Capital Corp by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Zenith Capital Corp Historical Marketcap From 2020 to 2025
Between 2020 and today, Zenith Capital Corp's market cap moved from $71.69 Million to $ 7.97 Million, with a yearly change of 130.26%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $7.97 Million | -54.55% |
| 2024 | $17.52 Million | -8.33% |
| 2023 | $19.12 Million | -14.29% |
| 2022 | $22.30 Million | +27.27% |
| 2021 | $17.52 Million | -75.56% |
| 2020 | $71.69 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Zenith Capital Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.97 Million USD |
| MoneyControl | $7.97 Million USD |
| MarketWatch | $7.97 Million USD |
| marketcap.company | $7.97 Million USD |
| Reuters | $7.97 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.